Accelerate your product's path to the market.
The journey from proof-of-concept to getting to commercial launch can be complex.
Speed to market is critical but cannot come at the expense of drug product quality. Accelerate your product's journey to commercial launch with our help.
What is the late drug development phase and how can you help accelerate through it?
Late phase clinical development includes Phase 2b and Phase 3 trials to establish the effectiveness, safety, and cost-effectiveness of a product on a larger scale in order to provide sufficient evidence for the drug's market approval submission. Commercial manufacture at scale of the product.
At Quotient Sciences, we support clinical trial materials manufacturing, registration and validation batches, and commercial scale to help your treatment reach the market.
Why partner with Quotient Sciences in your late drug development phase?
We provide the necessary expertise to turn promising molecules into successful, commercial drug products.
- Multidisciplinary scientific team with 30 years of experience
- Faster, more cost-effective route to market
- Shortens timelines by over 12 months
- Clinical data drives drug product optimization
- Streamlined outsourcing
Quotient Sciences Translational Pharmaceutics®
Leveraging the Quotient Sciences Translational Pharmaceutics® platform lets you reach late-phase trials, faster. Translational Pharmaceutics® enables us to develop late-phase products more efficiently. This means faster regulatory submissions, approvals, and market access for your new therapy.
